13.04
前日終値:
$12.88
開ける:
$12.97
24時間の取引高:
125.94K
Relative Volume:
2.12
時価総額:
$345.77M
収益:
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-3.98%
1か月 パフォーマンス:
+0.00%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
Carlsmed Inc Stock (CARL) Company Profile
CARL を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
CARL
Carlsmed Inc
|
13.04 | 349.48M | 0 | 0 | 0 | 0.00 |
![]()
VEEV
Veeva Systems Inc
|
290.86 | 46.10B | 2.86B | 780.66M | 1.19B | 4.72 |
![]()
TEM
Tempus Ai Inc
|
80.52 | 13.63B | 803.32M | -709.10M | -212.68M | -7.8003 |
![]()
DOCS
Doximity Inc
|
67.74 | 12.35B | 550.17M | 201.35M | 232.07M | 1.00 |
![]()
HQY
Healthequity Inc
|
89.82 | 7.74B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
WAY
Waystar Holding Corp
|
36.24 | 6.32B | 906.14M | -52.62M | 89.62M | -0.3621 |
Carlsmed Inc Stock (CARL) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-08-18 | 開始されました | BTIG Research | Buy |
2025-08-18 | 開始されました | BofA Securities | Buy |
2025-08-18 | 開始されました | Goldman | Buy |
2025-08-18 | 開始されました | Piper Sandler | Overweight |
2025-08-18 | 開始されました | Truist | Buy |
Carlsmed Inc (CARL) 最新ニュース
Carlsmed initiated with Buy at Truist on business potential - MSN
Why Is Carlsmed Stock Gaining Monday?Carlsmed (NASDAQ:CARL) - Benzinga
AI medtech firm Carlsmed prices $100.5M IPO - MSN
Carlsmed initiated with Buy at Truist on business potential (CARL) - Seeking Alpha
BofA Securities Initiates Coverage on Carlsmed With Buy Rating, $16 Price Target - MarketScreener
This Synaptics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Goldman Sachs Initiates Coverage on Carlsmed With Buy Rating, $19 Price Target - MarketScreener
Truist Securities initiates coverage on Carlsmed stock with Buy rating - Investing.com
Truist Initiates Carlsmed at Buy With $18 Price Target - MarketScreener
Piper Sandler initiates coverage on Carlsmed with an Overweight rating, PT of $18. - AInvest
Carlsmed stock initiated with Buy rating at BTIG on customized implant tech - Investing.com
Carlsmed stock initiated with Buy rating at BTIG on customized implant tech By Investing.com - Investing.com South Africa
Piper Sandler initiates Carlsmed stock with Overweight rating on custom implant potential - Investing.com India
Goldman Sachs initiates coverage on Carlsmed stock with Buy rating - Investing.com
Goldman Sachs initiates coverage on Carlsmed stock with Buy rating By Investing.com - Investing.com Nigeria
Carlsmed initiated with a Buy at Goldman Sachs - MSN
AI medtech firm Carlsmed to sell 6.7M shares in IPO - MSN
Carlsmed, Inc. shares fall 2.01% after-hours as it prepares to report Q2 2025 financial results. - AInvest
Carlsmed Inc. to Report Second Quarter 2025 Financial Results on August 28, 2025 - The Manila Times
Carlsmed to report Q2 2025 financial results on Aug 28, 2025. - AInvest
Big Boost for Personalized Cervical Fusion: Add-On Code - Orthopedics This Week
Heartflow raises $317M, pops 66% at market open - BioWorld MedTech
Carlsmed’s $100.5M IPO fuels 3D printed spinal implants growth - 3D Printing Industry
Carlsmed’s aprevo implants receive CMS NTAP for cervical fusion procedures - TipRanks
Carlsmed’s aprevo® Personalized Interbody Implants Receive CMS New Technology Add-On Payment (NTAP) for Cervical Fusion Procedures - Ortho Spine News
Carlsmed's Aprevo Implants Receive CMS NTAP Approval For Cervical Fusion Procedures Under FY2026 IPPS Final Rule - 富途牛牛
Carlsmed's Aprevo Personalized Interbody Implants Receive CMS NTAP for Cervical Fusion Procedures - AInvest
US Life Sciences IPOs Revive with Medtech Companies Leading the Way - AInvest
Medtech IPOs Spur Talk of Broader US Health-Care Listing Revival - Bloomberg.com
Carlsmed's Aprevo Powers First Personalized Cervical Spine Surgery - MarketScreener
Carlsmed announces completion of first aprevo cervical procedure - TipRanks
Carlsmed’s aprevo® Powers First Personalized Cervical Spine Surgery - Ortho Spine News
Carlsmed's Aprevo Powers First Personalized Cervical Spine Surgery. - AInvest
Carlsmed’s Nasdaq Debut Gets $100.5M - San Diego Business Journal
Carlsmed Launches $100.5 Million Initial Public Offering - Global Legal Chronicle
Carlsbad-based medical technology company begins trading on Nasdaq - MSN
Latham & Watkins Advises on Carlsmed, Inc.’s US$100.5 Million Initial Public Offering - Latham & Watkins LLP
Carlsmed Insider Bought Shares Worth $899,985, According to a Recent SEC Filing - MarketScreener
Carlsmed director Philip Young buys $900k in shares By Investing.com - Investing.com South Africa
Carlsmed (CARL) director Sidow buys $199,995 in shares By Investing.com - Investing.com India
Carlsmed (CARL) director Sidow buys $199,995 in shares - Investing.com Australia
Carlsmed director Philip Young buys $900k in shares - Investing.com
Carlsmed director Mittendorff buys $20 million in shares By Investing.com - Investing.com India
Carlsmed director Mittendorff buys $20 million in shares - Investing.com
Carlsmed Inc (CARL) 財務データ
Carlsmed Inc (CARL) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
Carlsmed Inc (CARL) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Sidow Kevin | Director |
Jul 24 '25 |
Buy |
15.00 |
13,333 |
199,995 |
59,566 |
Mittendorff Robert II | Director |
Jul 24 '25 |
Buy |
15.00 |
1,333,333 |
19,999,995 |
5,013,839 |
ROOT JONATHAN D | Director |
Jul 24 '25 |
Buy |
15.00 |
466,666 |
6,999,990 |
483,999 |
YOUNG PHILIP M | Director |
Jul 24 '25 |
Buy |
15.00 |
59,999 |
899,985 |
53,333 |
大文字化:
|
ボリューム (24 時間):